R. Ramírez-Roa

High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations.

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2020, Pharmacogenomics.

Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-Limited Settings: Conclusions From the Council for International Organizations of Medical Sciences-Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting.

E. Tarazona-Santos, A. Llerena, E. Terán, 2020, Clinical therapeutics.

Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population

A. Llerena, E. Peñas-Lledó, P. Dorado, 2020, The Pharmacogenomics Journal.

Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2019, Clinical pharmacology and therapeutics.

Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.

R. Barrantes, E. Tarazona-Santos, A. Llerena, 2018, Omics : a journal of integrative biology.